Skip to main content
    C

    Core Laboratories NV (CLB)

    Official site

    ENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE

    $8.38
    -0.06 (-0.77%)

    Market Cap: $387.21M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Core Laboratories NV (CLB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Core Laboratories NV (CLB) has a market cap of $387.21M and an enterprise value of $490.00M. Its trailing P/E of 15.5x is below its 10-year median of 29.4x. Its return on invested capital of 6.29% compares with a 3.50% median across 10 similar companies.

    Total Valuation

    Enterprise value is 26.55% above the market cap, as debt exceeds cash.

    Market Cap$387.21M
    Enterprise Value$490.00M
    Latest price (Nov 17, 2026)$8.38

    Key Dates

    The last ex-dividend date was Nov 9, 2026.

    Last Earnings DateOct 28, 2026
    Last Ex-Dividend DateNov 9, 2026
    Next Payment DateNov 30, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.36% in the quarter ended Sep 30, 2026 and shrank 1.17% a year over 2 years.

    Shares Outstanding46.71M
    Shares Change (YoY)-0.78%
    Shares Change (QoQ)-0.36%
    Share Count Growth (2Y CAGR)-1.17%

    Valuation Ratios

    Sales and book value multiples are 0.8x and 1.4x. Its year-end P/E ranged from 19.7x to 79.5x from 2016 to 2025.

    P/E Ratio15.5x
    Forward P/E16.6x
    P/S Ratio0.8x
    Forward P/S0.8x
    P/B Ratio1.4x
    P/TBV Ratio2.4x
    P/OCF Ratio15.7x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 9.2x EBITDA.

    EV / Earnings31.5x
    EV / Sales0.9x
    EV / EBITDA9.2x
    EV / EBIT12.6x

    Price Statistics

    The stock is down 45.49% over 52 weeks and trades 17.84% below its 50-day average.

    Beta (1Y)0.88
    52-Week Change-45.49%
    1-Month Change-17.30%
    3-Month Change-33.64%
    6-Month Change-38.83%
    5-Year Change-59.09%
    10-Year Change-89.03%
    Total Return (1Y)-45.23%
    Total Return (3Y CAGR)-22.75%
    Total Return (5Y CAGR)-19.70%
    Return vs SPY (1Y)-56.80%
    Max Drawdown (1Y)-57.32%
    Max Drawdown (3Y)-65.65%
    Sharpe Ratio (1Y)-1.28
    Correlation with SPY (1Y)0.26
    50-Day Average$10.20
    200-Day Average$13.23
    52-Week Range$8.44 to $20.29
    RSI (14 Days)30.0
    Average Volume (20 Days)720.85K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.19x current liabilities, and total debt is 0.45x shareholder equity.

    Current Ratio2.19x
    Quick Ratio1.60x
    Debt / Equity0.45x
    Debt / EBITDA2.30x
    Interest Coverage3.50x

    Returns and Efficiency

    Return on invested capital is 6.29% over the last 12 months, against a 5-year average of 9.62%.

    Return on Equity (ROE)5.60%
    Return on Assets (ROA)2.62%
    Return on Invested Capital (ROIC)6.29%
    Return on Capital Employed (ROCE)7.93%
    ROE (5Y Average)12.62%
    ROA (5Y Average)4.68%
    ROIC (5Y Average)9.62%
    Asset Turnover0.87x
    Inventory Turnover7.17x
    Receivables Turnover4.25x
    Cash Conversion Cycle102 days

    Taxes

    Income tax took 43.76% of pretax income over the last 12 months.

    Income Tax (TTM)$12.17M
    Effective Tax Rate43.76%

    Scores

    CLB has an Altman Z-Score of 2.52, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.52
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $516.74M over the last 12 months is down 0.15% from the 12 months before.

    Revenue$516.74M
    Revenue Growth (YoY)-0.15%
    Gross Profit$91.29M
    Operating Income$39.10M
    Pretax Income$27.80M
    Net Income$15.56M
    EBITDA$53.90M
    EBIT$38.92M
    Reported EPS (TTM)$0.54

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 46.83% of the $593.52M in total assets.

    Cash and Equivalents$21.38M
    Total Debt$124.17M
    Net Debt$102.79M
    Net Debt Per Share$2.20
    Working Capital$122.32M
    Shareholder Equity$277.97M
    Book Value Per Share$5.95
    Tangible Book Value$165.41M
    Tangible Book Per Share$3.54
    Total Assets$593.52M
    Total Liabilities$309.43M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $25.12M of capital spending, operating cash flow left -$429.00K of free cash flow.

    Operating Cash Flow$24.69M
    Capital Expenditures$25.12M
    Free Cash Flow-$429.00K
    FCF Per Share-$0.01
    Depreciation and Amortization$14.98M
    Dividends Paid$1.84M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 7.57%, against a 5-year average of 9.92%.

    Gross Margin17.67%
    Operating Margin7.57%
    Pretax Margin5.38%
    Net Margin3.01%
    EBITDA Margin10.43%
    EBIT Margin7.53%
    FCF Margin-0.08%
    Gross Margin (5Y Average)17.43%
    Operating Margin (5Y Average)9.92%
    Net Margin (5Y Average)5.40%

    Growth

    Revenue grew 2.44% a year over 3 years, and EPS 9.43% a year.

    Revenue Growth (3Y CAGR)+2.44%
    Revenue Growth (5Y CAGR)+1.56%
    EPS Growth (3Y CAGR)+9.43%
    EPS Growth (5Y CAGR)-0.77%
    FCF Growth (3Y CAGR)+14.78%
    FCF Growth (5Y CAGR)-13.48%
    Operating Income Growth (3Y CAGR)+6.73%
    Book Value Per Share Growth (2Y CAGR)+10.00%
    Tangible Book Per Share Growth (2Y CAGR)+14.97%

    Revenue and profit by year

    Dividends and Yields

    CLB pays out 12.01% of earnings as dividends.

    Dividend Per Share (Annual)$0.04
    Dividend Yield0.48%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)0.00%
    Dividend Growth (5Y CAGR)+5.92%
    Payout Ratio12.01%
    Earnings Yield6.45%
    FCF Yield-0.11%
    Shareholder Yield0.47%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Jul 9, 2010.

    Last Split DateJul 9, 2010
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 8 similar companies, CLB has the 6th highest P/E.

    P/E Ratio15.5x vs 17.8x median
    P/S Ratio0.8x vs 0.7x median
    ROIC6.29% vs 3.50% median
    Revenue Growth (Trailing 4 Quarters, YoY)-0.15% vs +11.34% median
    Dividend Yield0.48% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -0.17% and EPS growth at -4.72% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-0.17%
    EPS Growth Forecast (2Y CAGR)-4.72%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLB

    What is CLB's market cap?

    Core Laboratories NV has a market cap of $387.21M. Its enterprise value, which adds debt and subtracts cash, is $490.00M.

    What is CLB's P/E ratio?

    Core Laboratories NV has a trailing P/E ratio of 15.5x and a forward P/E of 16.6x.

    How many shares of CLB are outstanding?

    Core Laboratories NV has 46.71M shares outstanding. The count is down 0.78% from a year earlier.

    Does CLB pay a dividend?

    Yes. Core Laboratories NV pays $0.04 a share a year, a dividend yield of 0.48%.

    How much debt does CLB have?

    Core Laboratories NV has $124.17M of total debt and $21.38M of cash and equivalents, a net debt position of $102.79M.